Home › Compare › AZTEF vs JNJ

AZTEF vs JNJ: Dividend Comparison 2026

AZTEF yields 500000.00% · JNJ yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AZTEF wins by $252475121624236192.00M in total portfolio value
10 years
AZTEF
AZTEF
● Live price
500000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$252475121624236192.00M
Annual income
$179,970,099,914,313,700,000,000.00
Full AZTEF calculator →
JNJ
Johnson & Johnson
● Live price
2.14%
Share price
$242.49
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.5K
Annual income
$4,749.88
Full JNJ calculator →

Portfolio growth — AZTEF vs JNJ

📍 AZTEF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAZTEFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AZTEF + JNJ cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AZTEF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AZTEF
Annual income on $10K today (after 15% tax)
$42,500,000.00/yr
After 10yr DRIP, annual income (after tax)
$152,974,584,927,166,630,000,000.00/yr
JNJ
Annual income on $10K today (after 15% tax)
$182.28/yr
After 10yr DRIP, annual income (after tax)
$4,037.40/yr
At 15% tax rate, AZTEF beats the other by $152,974,584,927,166,630,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AZTEF + JNJ for your $10,000?

AZTEF: 50%JNJ: 50%
100% JNJ50/50100% AZTEF
Portfolio after 10yr
$126237560812118096.00M
Annual income
$89,985,049,957,156,840,000,000.00/yr
Blended yield
71.28%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

AZTEF
No analyst data
Altman Z
0.5
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-5.7% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AZTEF buys
0
JNJ buys
0
No recent congressional trades found for AZTEF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAZTEFJNJ
Forward yield500000.00% ✓2.14%
Annual dividend / share$2.00$5.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%28% ✓
Portfolio after 10y$252475121624236192.00M ✓$30.5K
Annual income after 10y$179,970,099,914,313,700,000,000.00 ✓$4,749.88
Total dividends collected$246974404501167104.00M ✓$15.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: AZTEF vs JNJ ($10,000, DRIP)

YearAZTEF PortfolioAZTEF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$25,010,700$25,000,000.00$10,594$274.49+$25.00M → AZTEF
2$29,244,868,926$29,218,107,476.64$11,294$360.69+$29244.86M → AZTEF
3$15,996,042,711,578$15,964,750,701,827.40$12,133$476.91+$15996042.70M → AZTEF
4$4,097,595,673,237,753$4,080,479,907,536,365.00$13,156$635.42+$4097595673.22M → AZTEF
5$492,827,571,123,448,100$488,443,143,753,083,800.00$14,432$854.61+$492827571123.43M → AZTEF
6$27,978,829,179,189,830,000$27,451,503,678,087,737,000.00$16,056$1,162.76+$27978829179189.81M → AZTEF
7$758,198,099,371,876,500,000$728,260,752,150,143,400,000.00$18,175$1,604.53+$758198099371876.50M → AZTEF
8$10,033,296,784,320,553,000,000$9,222,024,817,992,646,000,000.00$21,009$2,252.68+$10033296784320554.00M → AZTEF
9$67,761,702,532,637,870,000,000$57,026,074,973,414,870,000,000.00$24,911$3,229.73+$67761702532637872.00M → AZTEF
10$252,475,121,624,236,200,000,000$179,970,099,914,313,700,000,000.00$30,458$4,749.88+$252475121624236192.00M → AZTEF

AZTEF vs JNJ: Complete Analysis 2026

AZTEF — Stock

TV Azteca SAB de CV engages in the production and transmission of television programs. It operates through the following segments: Domestic Operation, United States, Guatemala and Honduras, Exports, Fiber Optic Network, and Golf. The Domestic Operation segment includes local stations, the operations relating to football, and internet teams. The United States segment sells exhibition rights in the territory of the United States of America. The Guatemala and Honduras segment offers television services. The Exports segment consists of the export of programs that were of great interest to global audiences in Latin American countries, and Europe mainly. The Fiber Optic Network segment refers to the construction, operation, and maintenance of the fiber network optics in Peru. The Golf segment represents golf tournament. The company was founded on June 2, 1993 and is headquartered in Mexico City, Mexico.

Full AZTEF Calculator →

JNJ — Healthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this AZTEF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AZTEF vs SCHDAZTEF vs JEPIAZTEF vs OAZTEF vs KOAZTEF vs MAINAZTEF vs ABBVAZTEF vs MRKAZTEF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.